Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C49H66N10O10S2 |
Molecular Weight | 1019.239 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)[C@H](N)CC5=CC=CC=C5)[C@@H](C)O
InChI
InChIKey=DEQANNDTNATYII-OULOTJBUSA-N
InChI=1S/C49H66N10O10S2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+/m1/s1
Molecular Formula | C49H66N10O10S2 |
Molecular Weight | 1019.239 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:50:22 UTC 2023
by
admin
on
Fri Dec 15 15:50:22 UTC 2023
|
Record UNII |
RWM8CCW8GP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
H01CB02
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
WHO-VATC |
QH01CB02
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
836621
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
116898
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
114698
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
NCI_THESAURUS |
C62799
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
114598
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
309310
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
NDF-RT |
N0000175904
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
FDA ORPHAN DRUG |
310710
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
LIVERTOX |
NBK547947
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
||
|
NDF-RT |
N0000000194
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID0048682
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
1980
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
448601
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
RWM8CCW8GP
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
Octreotide
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
D015282
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
5656
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
DB00104
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
100000092509
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
m8121
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | Merck Index | ||
|
OCTREOTIDE
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
CHEMBL1680
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
C711
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
SUB09417MIG
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
RWM8CCW8GP
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
7617
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | RxNorm | ||
|
83150-76-9
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY | |||
|
X-39
Created by
admin on Fri Dec 15 15:50:22 UTC 2023 , Edited by admin on Fri Dec 15 15:50:22 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
PARENT -> DERIVATIVE |
|
||
|
TARGET -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||